|
|
Biography |
|
|
Jacques-Francois Martin, Chairman and CEO of Parteurop Biographical Information. In 1976, Martin joined the Institut Mérieux as VP of Sales and Marketing, where he largely contributed to the international expansion of Mérieux. He was nominated CEO, in 1988, and successfully negotiated with the Government of Canada for the acquisition of Connaught Laboratories. In 1991, Martin set up Parteurop, a biotech consulting company based in Lyon, France. From September 1996 to September 1999, he was a Board member of INSERM (the French National Institute of Health). From 1994 to 1997, Martin served as the Chairman of the Biological Committee of the International Federation of Pharmaceutical Manufacturers Associations. As such, he was a member of the Scientific Advisory Group of Experts of WHO (SAGE). From November 1997 to June 2003 he was a member of the Board of the International AIDS Vaccine Initiative (IAVI). From 2000 to January 2005, Martin was the first President and CEO of the vaccine fund. He lead the fund’s efforts to provide lifesaving vaccines and other immunization program support to low-income countries, which facilitated his membership in the Board of GAVI (Global Alliance for Vaccines and Immunization). He is Chairman and CEO of Mymetics (Epalinges-Switzerland). He is also a member in the boards of several life sciences companies. Martin holds an MBA from HEC-Paris France. He is a member of the French Academy of Technologies and an officer in the French Order of Merit.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
|
|
|
|
|
|
|